Tuesday, August 20, 2019
wellness India Expo
Home Tags Panacea Biotec

Tag: Panacea Biotec

Panacea Biotec gets INR 992 crore funding boost by IndiaRF

Investment to be used for one-time settlement with existing lenders, working capital and growth requirements

Panacea Biotec gets USFDA’s nod for its generic breast cancer drug

The company is looking ahead at commercializing the what it calls the best product in the United States and several other markets worldwide in collaboration with Apotex.............

Post USFDA nod, Panacea Biotec set to launch Prasugrel tablets in...

The New Delhi based Panacea Biotec has received final approval from the US Food and Drug Administration to launch generic Prasugrel tablets in the American market..........

Panacea Biotec gets Ukrainian regulator’s green signal for its 22 medicines

On the basis of this approval, the company can now fast track the registration of these 22 medicinal products in other 49 countries...........

Panacea Biotec announces joint collaboration with Biopharma Inc

Under the collaboration, Panacea Biotec will be responsible for manufacturing and supply of the new drug entities of Biopharma Inc which again will be a distributor of these ANDAs in the United States and its territories..........

Panacea Biotec launches novel ‘EasySix’ vaccine for newborns

The top vaccine manufacturer spent almost a decade to develop world’s first fully liquid whole cell pertussis based vaccine........

Panacea launches tetravalent vaccine Easyfour-TT

Shares of Panacea Biotec surged more than 10 percent intraday Monday as the company launched world's first fully liquid tetravalent vaccine Easyfour-TT in India to protect children from vaccine-preventable diseases.....

Panacea Biotec increases availability of life saving drug Cilamin 250

The New Delhi based biotech firm, Panacea Biotec has said that it has increased the supply of the life saving drug, Cilamin250 that had witnessed shortage in the market...

Lupin scales new heights in India’s top pharma reputation list

There were 41 domestic and 17 international pharmaceutical brands listed in the study by BlueBytes conducted in association with TRA Research....